Antonelli Financial Advisors LLC bought a new stake in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 731 shares of the semiconductor company’s stock, valued at approximately $355,000.
Several other institutional investors and hedge funds have also bought and sold shares of SNPS. Douglass Winthrop Advisors LLC grew its holdings in shares of Synopsys by 10.6% in the fourth quarter. Douglass Winthrop Advisors LLC now owns 11,494 shares of the semiconductor company’s stock worth $5,579,000 after purchasing an additional 1,103 shares during the last quarter. Talos Asset Management LP purchased a new stake in Synopsys during the 4th quarter valued at $16,842,000. Royal London Asset Management Ltd. grew its holdings in Synopsys by 2.5% in the 4th quarter. Royal London Asset Management Ltd. now owns 168,251 shares of the semiconductor company’s stock worth $81,662,000 after acquiring an additional 4,092 shares during the last quarter. Algebris UK Ltd purchased a new position in shares of Synopsys in the fourth quarter valued at about $597,000. Finally, Generali Investments Management Co LLC bought a new position in shares of Synopsys during the fourth quarter valued at about $889,000. 85.47% of the stock is currently owned by institutional investors.
Wall Street Analysts Forecast Growth
Several research firms recently issued reports on SNPS. Redburn Atlantic assumed coverage on Synopsys in a research note on Monday, January 13th. They issued a “buy” rating and a $600.00 target price on the stock. Wells Fargo & Company reduced their target price on Synopsys from $540.00 to $520.00 and set an “equal weight” rating on the stock in a research note on Thursday, February 27th. Rosenblatt Securities reaffirmed a “buy” rating and issued a $660.00 price target on shares of Synopsys in a research note on Tuesday, February 25th. Morgan Stanley cut their price target on shares of Synopsys from $625.00 to $590.00 and set an “overweight” rating on the stock in a report on Monday, February 24th. Finally, Robert W. Baird decreased their price objective on shares of Synopsys from $644.00 to $630.00 and set an “outperform” rating for the company in a report on Thursday, December 5th. One investment analyst has rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $638.58.
Insider Activity
In other news, insider Geus Aart De sold 15,705 shares of the firm’s stock in a transaction on Thursday, March 6th. The stock was sold at an average price of $444.42, for a total transaction of $6,979,616.10. Following the completion of the transaction, the insider now directly owns 116,671 shares in the company, valued at $51,850,925.82. This trade represents a 11.86 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CRO Richard S. Mahoney sold 20,838 shares of the company’s stock in a transaction dated Wednesday, January 15th. The stock was sold at an average price of $506.01, for a total transaction of $10,544,236.38. Following the completion of the transaction, the executive now owns 1,460 shares in the company, valued at approximately $738,774.60. The trade was a 93.45 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 47,909 shares of company stock worth $22,794,835. Insiders own 0.62% of the company’s stock.
Synopsys Price Performance
NASDAQ:SNPS opened at $449.99 on Friday. Synopsys, Inc. has a one year low of $425.73 and a one year high of $624.80. The company’s 50-day simple moving average is $492.07 and its 200 day simple moving average is $506.55. The firm has a market capitalization of $69.58 billion, a P/E ratio of 30.99, a PEG ratio of 3.23 and a beta of 1.16.
Synopsys Company Profile
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Recommended Stories
- Five stocks we like better than Synopsys
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- Everything About Amazon Stock Signals a Buy—Time to Load Up?
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- 5 Reasons Five Below’s Stock Price Is Heading Higher This Year
- What Are Dividend Challengers?
- Broadcom: Why the Chip Stock Remains a Top Long-Term AI Play
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.